These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
577 related items for PubMed ID: 17980954
21. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Samaratunga H, Khoo K. Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444 [Abstract] [Full Text] [Related]
22. Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal-like urothelial cells: an immunohistochemical and histopathogenetic study. Mai KT, Hakim SW, Ball CG, Flood TA, Belanger EC. Pathol Int; 2014 Aug; 64(8):375-81. PubMed ID: 25143125 [Abstract] [Full Text] [Related]
23. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Fong A, Garcia E, Gwynn L, Lisanti MP, Fazzari MJ, Li M. Am J Clin Pathol; 2003 Jul; 120(1):93-100. PubMed ID: 12866378 [Abstract] [Full Text] [Related]
24. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. McKenney JK, Desai S, Cohen C, Amin MB. Am J Surg Pathol; 2001 Aug; 25(8):1074-8. PubMed ID: 11474293 [Abstract] [Full Text] [Related]
25. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Paner GP, Shen SS, Lapetino S, Venkataraman G, Barkan GA, Quek ML, Ro JY, Amin MB. Am J Surg Pathol; 2009 Jan; 33(1):91-8. PubMed ID: 18936687 [Abstract] [Full Text] [Related]
26. [Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas]. Moll R, Laufer J, Wu XR, Sun TT. Verh Dtsch Ges Pathol; 1993 Jan; 77():260-5. PubMed ID: 7511294 [Abstract] [Full Text] [Related]
27. Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini. Chastain EC, Oliva IV, Osunkoya AO. Pathology; 2012 Apr; 44(3):199-203. PubMed ID: 22406481 [Abstract] [Full Text] [Related]
28. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, Lin H, Pan CX, Tretiakova M, Baldridge LA, Cheng L. Hum Pathol; 2005 Jul; 36(7):718-23. PubMed ID: 16084939 [Abstract] [Full Text] [Related]
39. p63 gene expression study and early bladder carcinogenesis. Compérat E, Bièche I, Dargère D, Ferlicot S, Laurendeau I, Benoît G, Vieillefond A, Verret C, Vidaud M, Capron F, Bedossa P, Paradis V. Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096 [Abstract] [Full Text] [Related]